MetaCap

Inspire Medical Systems Inc. (INSP)

NYSE: INSPHealth CareMedical/Dental InstrumentsUSD

55.10-1.18 (-2.10%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

INSP stock chart

Technical analysis

Key statistics

All statistics
52-week range
38.91 – 147.03
Day range
54.92 – 56.93
Volume / Avg
552.32K / 765.67K
Beta
—

52-week range

$38.91$147.03

INSP stock today

Inspire Medical Systems (INSP) closed at $55.10 on Nov 20, down 2.10% (-$1.18), versus the S&P 500's 3.70% decline. At this level, INSP sits near the bottom of its 52-week range of $38.91 to $147.03: 62.5% below the high, set on Dec 10, 2025 and 41.6% above the low. INSP is down 40.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 38.7%.

Inspire Medical Systems trades at 16.4x its trailing twelve-month earnings per share of $3.35. Its forward P/E of 36.8x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Inspire Medical Systems

Company profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

Industry
Medical/Dental Instruments
CEO
Mr. Timothy P. Herbert
Headquarters
Golden Valley, MN
Employees
1,333
IPO year
2018

Financial highlights

Full financials

In fiscal 2025, Inspire Medical Systems generated $912.0 million in revenue, up 13.6% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $145.4 million (+171.8% year over year), for a net margin of 15.9% versus a median of -11.0% in the prior 5 years. Gross margin was 85.4% (up from 84.7%) and operating margin 5.6%.

Inspire Medical Systems annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$911.98M$802.80M$624.80M$407.86M$233.39M
Growth+13.60%+28.49%+53.19%+74.75%+102.28%
Net income$145.42M$53.51M$-21.15M$-44.88M$-42.04M
EPS (diluted)$4.89$1.75$-0.72$-1.60$-1.54

Analyst forecast

Forecast

Consensus (18 analysts)

hold

Avg. price target

$69.38+25.92%

  • Strong buy 0
  • Buy 4
  • Hold 11
  • Sell 1
  • Strong sell 2

Target range

Low $45.00High $93.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 2, 2026
EPS actual vs est.
$-0.84 vs $0.10
Surprise
-940.00%

INSP news

All INSP news

Inspire Medical Systems peers

Health Care sector
INSP peer companies
CompanyPrice% ChgMarket capCompare
XRAYDENTSPLY SIRONA Inc.8.29-2.36%$1.65Bvs INSP
LMATLeMaitre Vascular Inc.73.61-1.67%$1.68Bvs INSP
KMTSKestra Medical Technologies Ltd.25.10-5.75%$1.50Bvs INSP
PRCTPROCEPT BioRobotics Corporation24.70-4.08%$1.42Bvs INSP
NVCRNovoCure Limited10.71+0.19%$1.25Bvs INSP
TNDMTandem Diabetes Care Inc.17.46+3.93%$1.22Bvs INSP
DRTSAlpha Tau Medical Ltd.11.76+3.93%$1.09Bvs INSP
SIBNSI-BONE Inc.23.73-0.08%$1.07Bvs INSP

Indexes, lists and sector

Inspire Medical Systems stock FAQ

What is Inspire Medical Systems's stock price today?

INSP last traded at $55.10 as of Nov 20, 4:00 PM EST, down 2.10% on the day. Prices are delayed at least 15 minutes.

What is INSP's P/E ratio?

INSP trades at a trailing P/E ratio of 16.45 and a forward P/E of 36.85.

Who is Inspire Medical Systems's CEO?

Mr. Timothy P. Herbert is the chief executive officer of Inspire Medical Systems Inc., which has about 1,333 employees.

What is the INSP 52-week high?

The 52-week high for INSP is $147.03 and the 52-week low is $38.91. The stock is currently 62.5% below its high.

Compare INSP